Hem › Metastaserande cancer › North Carolina › Charlotte
Kliniska studier för Metastaserande cancer i Charlotte, NC
11 studier för Metastaserande cancer söker deltagare vid platser i och runt Charlotte (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekryterarFas 1/2
- Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- Levine Cancer Institute, Charlotte
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RekryterarFas 1/2
- Atrium Health Levine Cancer Institute, Charlotte
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekryterarFas 3
- Levine Cancer Institute, Charlotte
- Oncology Specialists of Charlotte, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekryterarFas 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi bort
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
RekryterarFas 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi bort
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RekryterarFas 1/2
- Levine Cancer Institute, Charlotte
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- Carolina BioOncology Institute, Huntersville · 13 mi bort
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
RekryterarFas 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi bort
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekryterarFas 1/2
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi bort
Metastaserande cancer-studier i andra städer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andra studier i Charlotte
- Cancer (alla typer)27 studier
- Bröstcancer22 studier
- Multipelt myelom21 studier
- Icke-småcellig lungcancer19 studier
- Akut myeloid leukemi16 studier
- Övervikt16 studier
- Övervikt15 studier
- Kolorektal cancer13 studier
- Äggstockscancer12 studier
- Hjärtsvikt11 studier
- Plattenepitelcancer i huvud och hals10 studier
- KOL9 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.